임상시험

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

NCT: NCT05557123 · COMPLETED

NCT IDNCT05557123

상태COMPLETED

시작일2022-03-10

완료2025-12-16

SponsorSeoul National University Bundang Hospital (OTHER)

First posted2022-09-27

Last updated2026-05-19

간략 요약

RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.